Skip to main content
Erschienen in: European Journal of Trauma and Emergency Surgery 2/2018

29.07.2017 | Original Article

The natural history of perforated foregut ulcers after repair by omental patching or primary closure

verfasst von: D. Smith, M. Roeser, J. Naranjo, J. A. Carr

Erschienen in: European Journal of Trauma and Emergency Surgery | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The treatment of perforated foregut ulcers by omental patching (OP) or primary closure has mostly replaced vagotomy and pyloroplasty/antrectomy (VPA). We sought to determine the natural history and recurrence rate of ulceration in patients treated by omental patching or primary closure.

Study design

An 11-year retrospective study.

Results

From 2004 through 2015, 94 patients had perforated foregut ulcers, 53 gastric, and 41 duodenal. 77 (82%) were treated by OP alone (study group) and 17 (18%) were treated with VPA (comparison group). All OP patients were discharged on PPIs, but only 86% took the drugs for a median of 22 months (1–192, SD 40). Endoscopy in the OP group showed recurrent ulcers in nine (12% recurrence rate) and gastritis in three (4%) This group also had three later recurrent perforations. Another recurrent ulcer hemorrhaged causing death (3% late mortality). Two other patients required non-emergent re-do ulcer operations for recurrent disease/symptoms (surgical re-intervention rate 4%). Total length of follow-up was median 44 months (1–192, SD 40) and was complete in 82 (87%). 18 (23%) patients in the OP group developed recurrent abdominal pain attributed to ulcer disease during follow-up, compared to 2 (12%) in the VPA group (p = 0.15). No patient in the VPA group had an endoscopic recurrence or re-intervention.

Conclusion

Omental patching does not correct the underlying disease process which causes foregut perforation, and has a 12% endoscopically proven recurrent ulceration rate and a 23% incidence of recurrent symptoms within 44 months. Patients tend to stop taking PPIs after 22 months at which time their risk increases.
Literatur
1.
Zurück zum Zitat Satoh K, Yoshino J, Akamatsu T, et al. Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol. 2016;51:177–94.CrossRefPubMed Satoh K, Yoshino J, Akamatsu T, et al. Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol. 2016;51:177–94.CrossRefPubMed
2.
Zurück zum Zitat Wang YR, Richter JE, Dempsey DT. Trends and outcomes of hospitalizations for peptic ulcer disease in the United States, 1993 to 2006. Ann Surg. 2010;251:51–8.CrossRefPubMed Wang YR, Richter JE, Dempsey DT. Trends and outcomes of hospitalizations for peptic ulcer disease in the United States, 1993 to 2006. Ann Surg. 2010;251:51–8.CrossRefPubMed
3.
Zurück zum Zitat Lo HC, Wu SC, Huang HC, et al. Laparoscopic simple closure alone is adequate for low risk patients with perforated peptic ulcer. World J Surg. 2011;35:1873–8.CrossRefPubMed Lo HC, Wu SC, Huang HC, et al. Laparoscopic simple closure alone is adequate for low risk patients with perforated peptic ulcer. World J Surg. 2011;35:1873–8.CrossRefPubMed
4.
Zurück zum Zitat Ng EK, Lam YH, Sung JJ, et al. Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation. Ann Surg. 2000;231:153–8.CrossRefPubMedPubMedCentral Ng EK, Lam YH, Sung JJ, et al. Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation. Ann Surg. 2000;231:153–8.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Malkov IS, Zaynutdinov AM, Veliyev NA, et al. Laparoscopic and endoscopic management of perforated duodenal ulcers. J Am Coll Surg. 2004;198:352–5.CrossRefPubMed Malkov IS, Zaynutdinov AM, Veliyev NA, et al. Laparoscopic and endoscopic management of perforated duodenal ulcers. J Am Coll Surg. 2004;198:352–5.CrossRefPubMed
7.
Zurück zum Zitat Tokunaga Y, Hata K, Ryo J, et al. Density of Helicobacter pylori infection in patients with peptic ulcer perforation. J Am Coll Surg. 1998;186:659–63.CrossRefPubMed Tokunaga Y, Hata K, Ryo J, et al. Density of Helicobacter pylori infection in patients with peptic ulcer perforation. J Am Coll Surg. 1998;186:659–63.CrossRefPubMed
8.
Zurück zum Zitat Datsis AC, Rogdakis A, Kekelos S, et al. Simple closure of chronic duodenal ulcer perforation in the era of Helicobacter pylori: an old procedure, today’s solution. Hepatogastroenterology. 2003;50:1396–8.PubMed Datsis AC, Rogdakis A, Kekelos S, et al. Simple closure of chronic duodenal ulcer perforation in the era of Helicobacter pylori: an old procedure, today’s solution. Hepatogastroenterology. 2003;50:1396–8.PubMed
9.
Zurück zum Zitat Gibson JB, Behrman SW, Fabian TC, et al. Gastric outlet obstruction resulting from peptic ulcer disease requiring surgical intervention is infrequently associated with Helicobacter pylori infection. J Am Coll Surg. 2000;191:32–7.CrossRefPubMed Gibson JB, Behrman SW, Fabian TC, et al. Gastric outlet obstruction resulting from peptic ulcer disease requiring surgical intervention is infrequently associated with Helicobacter pylori infection. J Am Coll Surg. 2000;191:32–7.CrossRefPubMed
10.
Zurück zum Zitat Brock J, Sauaia A, Ahnen D, et al. Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease: results from a quality improvement project. JAMA. 2001;286:1985–93.CrossRefPubMed Brock J, Sauaia A, Ahnen D, et al. Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease: results from a quality improvement project. JAMA. 2001;286:1985–93.CrossRefPubMed
11.
Zurück zum Zitat Wong CS, Chia CF, Lee HC, et al. Eradication of Helicobacter pylori for prevention of ulcer recurrence after simple closure of perforated peptic ulcer: a meta-analysis of randomized controlled trials. J Surg Res. 2013;182:219–26.CrossRefPubMed Wong CS, Chia CF, Lee HC, et al. Eradication of Helicobacter pylori for prevention of ulcer recurrence after simple closure of perforated peptic ulcer: a meta-analysis of randomized controlled trials. J Surg Res. 2013;182:219–26.CrossRefPubMed
12.
Zurück zum Zitat Yoon SB, Park JM, Lee JY, et al. Long-term pretreatment with proton pump inhibitor and Helicobacter pylori eradication rates. World J Gastroenterol. 2014;20:1061–6.CrossRefPubMedPubMedCentral Yoon SB, Park JM, Lee JY, et al. Long-term pretreatment with proton pump inhibitor and Helicobacter pylori eradication rates. World J Gastroenterol. 2014;20:1061–6.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Chan CC, Chien NH, Lee CL, et al. Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia. BMC Gastroenterol. 2015;15:170–5.CrossRefPubMedPubMedCentral Chan CC, Chien NH, Lee CL, et al. Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia. BMC Gastroenterol. 2015;15:170–5.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Gopal R, Elamurugan TP, Kate V, et al. Standard triple versus levofloxacin based regimen for eradication of Helicobacter pylori. World J Gastrointest Pharmacol Ther. 2013;4:23–7.CrossRefPubMedPubMedCentral Gopal R, Elamurugan TP, Kate V, et al. Standard triple versus levofloxacin based regimen for eradication of Helicobacter pylori. World J Gastrointest Pharmacol Ther. 2013;4:23–7.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Othman F, Card TR, Crooks CJ. Proton pump inhibitor prescribing patterns in the UK: a primary care database study. Pharmacoepidemiol Drug Saf. 2016;25:1079–87.CrossRefPubMed Othman F, Card TR, Crooks CJ. Proton pump inhibitor prescribing patterns in the UK: a primary care database study. Pharmacoepidemiol Drug Saf. 2016;25:1079–87.CrossRefPubMed
16.
Zurück zum Zitat Jackson LR, Peterson ED, McCoy LA, et al. Impact of proton pump inhibitor use on the comparative effectiveness and safety of prasugrel versus clopidogrel: insights from the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study. J Am Heart Assoc. 2016;5:17–23.CrossRef Jackson LR, Peterson ED, McCoy LA, et al. Impact of proton pump inhibitor use on the comparative effectiveness and safety of prasugrel versus clopidogrel: insights from the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study. J Am Heart Assoc. 2016;5:17–23.CrossRef
17.
Zurück zum Zitat Sherwood MW, Melloni C, Jones WS, et al. Individual proton pump inhibitors and outcomes in patients with coronary artery disease on dual antiplatelet therapy: a systematic review. J Am Heart Assoc. 2015;4:78–83.CrossRef Sherwood MW, Melloni C, Jones WS, et al. Individual proton pump inhibitors and outcomes in patients with coronary artery disease on dual antiplatelet therapy: a systematic review. J Am Heart Assoc. 2015;4:78–83.CrossRef
18.
Zurück zum Zitat Fraser LA, Leslie WD, Targownik LE, et al. The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporos Int. 2013;24:1161–8.CrossRefPubMed Fraser LA, Leslie WD, Targownik LE, et al. The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporos Int. 2013;24:1161–8.CrossRefPubMed
19.
Zurück zum Zitat Mutlu GM, Mutlu EA, Factor P. Prevention and treatment of gastrointestinal complications in patients on mechanical ventilation. Am J Respir Med. 2003;2:395–411.CrossRefPubMed Mutlu GM, Mutlu EA, Factor P. Prevention and treatment of gastrointestinal complications in patients on mechanical ventilation. Am J Respir Med. 2003;2:395–411.CrossRefPubMed
20.
Zurück zum Zitat McCarthy DM. Comparative toxicity of nonsteroidal anti-inflammatory drugs. Am J Med. 1999;107:37S–46S.CrossRefPubMed McCarthy DM. Comparative toxicity of nonsteroidal anti-inflammatory drugs. Am J Med. 1999;107:37S–46S.CrossRefPubMed
21.
Zurück zum Zitat Masuda E, Kawano S, Michida T, et al. Plasma and gastric mucosal endothelin-1 concentrations in patients with peptic ulcer. Dig Dis Sci. 1997;42:314–8.CrossRefPubMed Masuda E, Kawano S, Michida T, et al. Plasma and gastric mucosal endothelin-1 concentrations in patients with peptic ulcer. Dig Dis Sci. 1997;42:314–8.CrossRefPubMed
22.
Zurück zum Zitat Iaquinto G, Giardullo N, Taccone W, et al. Role of endogenous endothelin-1 in ethanol-induced gastric mucosal damage in humans. Dig Dis Sci. 2003;48:663–9.CrossRefPubMed Iaquinto G, Giardullo N, Taccone W, et al. Role of endogenous endothelin-1 in ethanol-induced gastric mucosal damage in humans. Dig Dis Sci. 2003;48:663–9.CrossRefPubMed
23.
Zurück zum Zitat Fennerty MB. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med. 2002;30:S351–5.CrossRefPubMed Fennerty MB. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med. 2002;30:S351–5.CrossRefPubMed
24.
Zurück zum Zitat Tytgat GN. Etiopathogenetic principles and peptic ulcer disease classification. Dig Dis. 2011;29:454–8.CrossRefPubMed Tytgat GN. Etiopathogenetic principles and peptic ulcer disease classification. Dig Dis. 2011;29:454–8.CrossRefPubMed
25.
Zurück zum Zitat Bashinskaya B, Nahed BV, Redjal N, et al. Trends in peptic ulcer disease and the identification of Helicobacter pylori as a causative organism: population-based estimates from the US Nationwide Inpatient Sample. J Glob Infect Dis. 2011;3:366–70.CrossRefPubMedPubMedCentral Bashinskaya B, Nahed BV, Redjal N, et al. Trends in peptic ulcer disease and the identification of Helicobacter pylori as a causative organism: population-based estimates from the US Nationwide Inpatient Sample. J Glob Infect Dis. 2011;3:366–70.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Smith JW, Mathis T, Benns MV, et al. Socioeconomic disparities in the operative management of peptic ulcer disease. Surgery. 2013;154:672–8.CrossRefPubMed Smith JW, Mathis T, Benns MV, et al. Socioeconomic disparities in the operative management of peptic ulcer disease. Surgery. 2013;154:672–8.CrossRefPubMed
27.
Zurück zum Zitat Zelickson MS, Bronder CM, Johnson BL, et al. Helicobacter pylori is not the predominant etiology for peptic ulcers requiring operation. Am Surg. 2011;77:1054–60.PubMed Zelickson MS, Bronder CM, Johnson BL, et al. Helicobacter pylori is not the predominant etiology for peptic ulcers requiring operation. Am Surg. 2011;77:1054–60.PubMed
28.
Zurück zum Zitat Smith BR, Wilson SE. Impact of nonresective operations for complicated peptic ulcer disease in a high-risk population. Am Surg. 2010;76:1143–6.PubMed Smith BR, Wilson SE. Impact of nonresective operations for complicated peptic ulcer disease in a high-risk population. Am Surg. 2010;76:1143–6.PubMed
29.
Zurück zum Zitat Schroder VT, Pappas TN, Vaslef SN, et al. Vagotomy/drainage is superior to local oversew in patients who require emergency surgery for bleeding peptic ulcers. Ann Surg. 2014;259:1111–8.CrossRefPubMed Schroder VT, Pappas TN, Vaslef SN, et al. Vagotomy/drainage is superior to local oversew in patients who require emergency surgery for bleeding peptic ulcers. Ann Surg. 2014;259:1111–8.CrossRefPubMed
30.
Zurück zum Zitat Yoon K, Kim N, Nam RH, et al. Ultimate eradication rate of Helicobacter pylori after first, second, or third-line therapy in Korea. J Gastroenterol Hepatol. 2015;30:490–5.CrossRefPubMed Yoon K, Kim N, Nam RH, et al. Ultimate eradication rate of Helicobacter pylori after first, second, or third-line therapy in Korea. J Gastroenterol Hepatol. 2015;30:490–5.CrossRefPubMed
32.
Zurück zum Zitat Raymond J, Thiberge JM, Dauga C. Diagnosis of Helicobacter pylori recurrence: relapse or reinfection? Usefulness of molecular tools. Scand J Gastroenterol. 2016;51:672–8.CrossRefPubMed Raymond J, Thiberge JM, Dauga C. Diagnosis of Helicobacter pylori recurrence: relapse or reinfection? Usefulness of molecular tools. Scand J Gastroenterol. 2016;51:672–8.CrossRefPubMed
33.
Zurück zum Zitat Chung WC, Jeon EJ, Kim DB, et al. Clinical characteristics of Helicobacter pylori-negative drug-negative peptic ulcer bleeding. World J Gastroenterol. 2015;21:8636–43.CrossRefPubMedPubMedCentral Chung WC, Jeon EJ, Kim DB, et al. Clinical characteristics of Helicobacter pylori-negative drug-negative peptic ulcer bleeding. World J Gastroenterol. 2015;21:8636–43.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Bornman PC, Theodorou NA, Jeffery PC, et al. Simple closure of perforated duodenal ulcer: a prospective evaluation of a conservative management policy. Br J Surg. 1990;77:73–7.CrossRefPubMed Bornman PC, Theodorou NA, Jeffery PC, et al. Simple closure of perforated duodenal ulcer: a prospective evaluation of a conservative management policy. Br J Surg. 1990;77:73–7.CrossRefPubMed
35.
Zurück zum Zitat El-Nakeeb A, Fikry A, Abd el-Hamed TM, et al. Effect of Helicobacter pylori eradication on ulcer recurrence after simple closure of perforated duodenal ulcer. Int J Surg. 2009;7:126–9.CrossRefPubMed El-Nakeeb A, Fikry A, Abd el-Hamed TM, et al. Effect of Helicobacter pylori eradication on ulcer recurrence after simple closure of perforated duodenal ulcer. Int J Surg. 2009;7:126–9.CrossRefPubMed
36.
Zurück zum Zitat Schuster KM, Feuer WJ, Barquist ES. Outcomes of cocaine-induced gastric perforations repaired with an omental patch. J Gastrointest Surg. 2007;11:1560–3.CrossRefPubMed Schuster KM, Feuer WJ, Barquist ES. Outcomes of cocaine-induced gastric perforations repaired with an omental patch. J Gastrointest Surg. 2007;11:1560–3.CrossRefPubMed
Metadaten
Titel
The natural history of perforated foregut ulcers after repair by omental patching or primary closure
verfasst von
D. Smith
M. Roeser
J. Naranjo
J. A. Carr
Publikationsdatum
29.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Trauma and Emergency Surgery / Ausgabe 2/2018
Print ISSN: 1863-9933
Elektronische ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-017-0825-3

Weitere Artikel der Ausgabe 2/2018

European Journal of Trauma and Emergency Surgery 2/2018 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.